HMS Capital Management’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-5,816
Closed -$614K 121
2024
Q4
$614K Sell
5,816
-733
-11% -$78.6K 0.3% 60
2024
Q3
$707K Buy
6,549
+702
+12% +$76.6K 0.35% 57
2024
Q2
$635K Buy
5,847
+370
+7% +$43.6K 0.33% 57
2024
Q1
$723K Sell
5,477
-202
-4% -$25.2K 0.4% 54
2023
Q4
$691K Sell
5,679
-2,872
-34% -$320K 0.42% 51
2023
Q3
$960K Buy
8,551
+931
+12% +$118K 0.64% 44
2023
Q2
$1.11M Buy
+7,620
New +$1.04M 0.67% 42

Other funds holding ZBH

HMS Capital Management's ZBH Position: Q1 2025 in Review

HMS Capital Management sold out of Zimmer Biomet (ZBH) in Q1 2025, closing a stake of 5,816 shares — an estimated $614K sold.

HMS Capital Management first reported a position in ZBH in Q2 2023 and held it in 7 quarters. The position peaked at $1.11M in Q2 2023. 1,000 funds tracked by Wall St. Rank hold ZBH as of Q1 2025.

  • HMS Capital Management reported no remaining Zimmer Biomet position as of Q1 2025 after selling out during the quarter.
  • HMS Capital Management sold 5,816 Zimmer Biomet shares in Q1 2025, an estimated $614K.
  • HMS Capital Management first reported a position in Zimmer Biomet in Q2 2023 and held it in 7 quarters.
  • HMS Capital Management's Zimmer Biomet position peaked at $1.11M in Q2 2023.
  • 1,000 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2025.

Based on HMS Capital Management's 13F filing for Q1 2025, filed 14 May 2025.